Source link : https://newshealth.biz/health-news/elranatamab-based-triplet-effective-in-transplant-ineligible-myeloma/
(MedPage Today) — TORONTO — A three-drug combination involving the B-cell maturation antigen (BCMA)-CD3 bispecific antibody elranatamab (Elrexfio) was associated with high response rates and manageable toxicity in newly diagnosed, transplant… Source link : https://www.medpagetoday.com/meetingcoverage/ims/117536 Author : Publish date : 2025-09-18 21:03:00 Copyright for syndicated content belongs to the linked Source.
The post Elranatamab-Based Triplet Effective in Transplant-Ineligible Myeloma first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-18 21:03:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8